CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 46 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,994,000 | +4.8% | 108,545 | +4.6% | 0.00% | 0.0% |
| Q3 2020 | $1,903,000 | -4.5% | 103,798 | -22.1% | 0.00% | 0.0% |
| Q2 2020 | $1,993,000 | +83.5% | 133,271 | +93.7% | 0.00% | +33.3% |
| Q1 2020 | $1,086,000 | -0.7% | 68,793 | +2.0% | 0.00% | +50.0% |
| Q4 2019 | $1,094,000 | +59.2% | 67,474 | +46.1% | 0.00% | +100.0% |
| Q3 2019 | $687,000 | +1045.0% | 46,188 | +925.5% | 0.00% | – |
| Q4 2016 | $60,000 | – | 4,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 38,300 | $555,000 | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 34,571 | $501,000 | 0.01% |
| Acrospire Investment Management LLC | 300 | $4,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 25,798 | $374,000 | 0.00% |
| RHUMBLINE ADVISERS | 14,614 | $212,000 | 0.00% |
| BlackRock Investment Management, LLC | 47,237 | $685,000 | 0.00% |
| BlackRock Fund Advisors | 336,772 | $4,883,000 | 0.00% |
| NORTHERN TRUST CORP | 135,559 | $1,966,000 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 11,406 | $165,000 | 0.00% |
| STRS OHIO | 1,500 | $21,000 | 0.00% |